Topic Review
Antioxidant Bioactive Molecules against Ischemic Stroke
Stroke is a major contributor to global mortality and disability. While reperfusion is essential for preventing neuronal death in the penumbra, it also triggers cerebral ischemia-reperfusion injury, a paradoxical injury primarily caused by oxidative stress, inflammation, and blood–brain barrier disruption. An oxidative burst inflicts marked cellular damage, ranging from alterations in mitochondrial function to lipid peroxidation and the activation of intricate signalling pathways that can even lead to cell death.
  • 116
  • 05 Mar 2024
Topic Review
AI Applications in Pancreatic Ductal Adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) stands out as the predominant malignant neoplasm affecting the pancreas, characterized by a poor prognosis, in most cases patients being diagnosed in a nonresectable stage. Image-based artificial intelligence (AI) models implemented in tumor detection, segmentation, and classification could improve diagnosis with better treatment options and increased survival. 
  • 177
  • 05 Mar 2024
Topic Review
Correlation of NETs to Atherosclerosis and Implication
Neutrophil extracellular traps (NETs) have attracted much attention recently, beyond elemental host immunity, due to their fundamental implication in a variety of pathologic conditions and widespread impactful diseases. Atherosclerotic cardiovascular disease (ASCVD) is one of them, and a major cause of mortality and disability worldwide. Consequently, years of basic and clinical research were dedicated to shedding light on every possible pathophysiologic mechanism that could be used as an effective prevention and treatment tool to ameliorate its burden. This led to the development of complex and prevention protocols and regimens that are now widely used, with lipid-lowering treatment being the current cornerstone; however, this is not adequate to alleviate the residual cardiovascular risk, which remains prominent. 
  • 105
  • 05 Mar 2024
Topic Review
A Regulatory Perspective on Biosimilar Medicines
By definition, biosimilar medicinal products are biological medicinal products that are similar to other biological medicinal products that are already on the market—the reference medicinal products.
  • 287
  • 05 Mar 2024
Topic Review
miR-Based Treatments for Acute Respiratory Distress Syndrome
Acute Respiratory Distress Syndrome (ARDS) is characterized by lung inflammation and increased membrane permeability, which represents the leading cause of mortality in ICUs. Mechanical ventilation strategies are at the forefront of supportive approaches for ARDS. Recently, an increasing understanding of RNA biology, function, and regulation, as well as the success of RNA vaccines, has spurred enthusiasm for the emergence of novel RNA-based therapeutics. The most common types of RNA seen in development are silencing (si)RNAs, antisense oligonucleotide therapy (ASO), and messenger (m)RNAs that collectively account for 80% of the RNA therapeutics pipeline. These three RNA platforms are the most mature, with approved products and demonstrated commercial success. 
  • 132
  • 05 Mar 2024
Topic Review
FLASH Radiotherapy
FLASH radiotherapy (RT) is considered one of the most promising revolutions in radiation oncology, placing itself at the intersection of technology, physics, and biology. The unique healthy tissue-sparing effect and, at the same time, the equivalent tumor response have already been identified in vivo for multiple organ systems, such as the lung, brain, skin, intestine, and blood, and even in the first human patient.
  • 161
  • 05 Mar 2024
Topic Review
Stem Cell-Derived Extracellular Vesicles in Systemic Lupus Erythematosus
Systemic lupus erythematosus (SLE) is a multisystemic autoimmune disease that affects nearly 3.41 million people globally, with 90% of the cases affecting women of childbearing age. Extracellular vesicles (EVs) can reduce the pro-inflammatory cytokines and increase the anti-inflammatory cytokines. Moreover, EVs can increase the levels of regulatory T cells, thus reducing inflammation. EVs also have the potential to regulate B cells to alleviate SLE and reduce its adverse effects. 
  • 369
  • 05 Mar 2024
Topic Review
Adjuvant Radiotherapy in the Treatment of Breast Cancer
The role of postmastectomy radiotherapy and regional nodal irradiation after radical mastectomy is defined in high-risk patients with locally advanced tumors, positive margins, and unfavorable biology. The benefit of postmastectomy radiotherapy in intermediate-risk patients (T3N0 tumors) remains a matter of controversy. It has been demonstrated that radiotherapy after breast-conserving surgery lowers the locoregional recurrence rate compared with surgery alone and improves the overall survival rate. In patients with four or more positive lymph nodes or extracapsular extension, regional lymph node irradiation is indicated regardless of the surgery type (breast-conserving surgery or mastectomy). Despite the consensus that patients with more than three positive lymph nodes should be treated with radiotherapy, there is controversy regarding the recommendations for patients with one to three involved lymph nodes. In patients with N0 disease with negative findings on axillary surgery, there is a trend to administer regional lymph node irradiation in patients with a high risk of recurrence. In patients treated with neoadjuvant systemic therapy and mastectomy, adjuvant radiotherapy should be administered in cases of clinical stage III and/or ≥ypN1. In patients treated with neoadjuvant systemic therapy and breast-conserving surgery, postoperative radiotherapy is indicated irrespective of pathological response.
  • 92
  • 05 Mar 2024
Topic Review
Epigenetic Implications in Glaucoma Neurodegenerative Disease
Glaucoma, a complex and multifactorial neurodegenerative disorder, is a leading cause of irreversible blindness worldwide. Despite significant advancements in the understanding of its pathogenesis and management, early diagnosis and effective treatment of glaucoma remain major clinical challenges. Epigenetic modifications, encompassing deoxyribonucleic acid (DNA) methylation, histone modifications, and non-coding RNAs, have emerged as critical regulators of gene expression and cellular processes.
  • 102
  • 04 Mar 2024
Topic Review
Possible Therapeutic Strategies for ADPKD Patients
Gender exerts a significant influence on the occurrence and progression of many renal diseases, including ADPKD. ADPKD, impacting roughly 12 million individuals globally, affects both men and women equally. Mutations in PKD1 and PKD2 genes contribute to ADPKD, with gender playing a crucial role in disease manifestation and progression.
  • 98
  • 04 Mar 2024
  • Page
  • of
  • 1352
Video Production Service